• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种直接的分子策略,用于回溯调查 SARS-CoV-2 VOC202012/01 B.1.1.7 变异株的传播。

A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.

机构信息

Department of Biomedical Sciences, Division of Microbiology and Virology, University of Sassari, 07100 Sassari, Italy.

Microbiologia e Virologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy.

出版信息

J Infect Dev Ctries. 2021 Mar 7;15(2):242-246. doi: 10.3855/jidc.14972.

DOI:10.3855/jidc.14972
PMID:33690207
Abstract

The spread of new SARS-CoV-2 variants represents a serious threat worldwide, thus rapid and cost-effective methods are required for their identification. Since November 2020, the TaqPath COVID-19 assay (Thermo Fisher Scientific) has been used to identify viral strains of the new lineage B.1.1.7, since it fails to detect the S-gene with the ∆69/70 deletion. Here, we proposed S-gene mutations screening with the Allplex SARS-CoV-2 assay (Seegene), another widely used RT-PCR test that targets Sarbecovirus E, SARS-CoV-2 N, and RdRp/S genes. Accordingly, we evaluated the S gene amplification curve pattern compared to those of the other genes. Exploiting an Allplex assay-generated dataset, we screened 663 RT-PCR digital records, including all SARS-CoV-2 respiratory samples tested in our laboratory with the Allplex assay between January 1st and February 25th, 2021. This approach enabled us to detect 64 samples with peculiar non-sigmoidal amplification curves. Sequencing a selected group of 4 RNA viral genomes demonstrated that those curves were associated with B.1.1.7 variant strains. Our results strongly suggest that B.1.1.7 variant spread has begun in this area at least since January and imply the potential of these analytical methods to track and characterize the spread of B.1.1.7 strains in those areas where Allplex SARS-CoV-2 datasets have been previously recorded.

摘要

新的 SARS-CoV-2 变体的传播在全球范围内构成了严重威胁,因此需要快速且具有成本效益的方法来识别它们。自 2020 年 11 月以来,TaqPath COVID-19 检测(赛默飞世尔科技)已用于鉴定新谱系 B.1.1.7 的病毒株,因为它无法检测到具有 ∆69/70 缺失的 S 基因。在这里,我们提出了使用另一种广泛使用的 RT-PCR 检测方法 Allplex SARS-CoV-2 检测(Seegene)进行 S 基因突变筛查,该检测方法针对 Sarbecovirus E、SARS-CoV-2 N 和 RdRp/S 基因。因此,我们评估了与其他基因相比的 S 基因扩增曲线模式。利用 Allplex 检测产生的数据集,我们筛选了 663 个 RT-PCR 数字记录,包括 2021 年 1 月 1 日至 2 月 25 日期间我们实验室用 Allplex 检测进行的所有 SARS-CoV-2 呼吸道样本。这种方法使我们能够检测到 64 个具有特殊非正弦扩增曲线的样本。对一组 4 个 RNA 病毒基因组进行测序表明,这些曲线与 B.1.1.7 变体株有关。我们的结果强烈表明,至少从 1 月开始,该变体在该地区已经开始传播,并且这些分析方法有可能在先前记录有 Allplex SARS-CoV-2 数据集的地区跟踪和表征 B.1.1.7 株的传播。

相似文献

1
A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.一种直接的分子策略,用于回溯调查 SARS-CoV-2 VOC202012/01 B.1.1.7 变异株的传播。
J Infect Dev Ctries. 2021 Mar 7;15(2):242-246. doi: 10.3855/jidc.14972.
2
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.开发扩增抑制突变系统-实时荧光定量 RT-PCR 检测方法,快速灵敏地筛查关注的 SARS-CoV-2 变异株。
Microbiol Spectr. 2022 Feb 23;10(1):e0143821. doi: 10.1128/spectrum.01438-21. Epub 2022 Jan 5.
3
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
4
Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.实时 RT-PCR 等位基因鉴别检测法用于检测与关注变异株 B.1.1.7 相关的 SARS-CoV-2 刺突蛋白 N501Y 突变。
Microbiol Spectr. 2022 Feb 23;10(1):e0068121. doi: 10.1128/spectrum.00681-21. Epub 2022 Feb 16.
5
Rapid and High-Throughput Reverse Transcriptase Quantitative PCR (RT-qPCR) Assay for Identification and Differentiation between SARS-CoV-2 Variants B.1.1.7 and B.1.351.快速高通量逆转录实时定量 PCR(RT-qPCR)检测方法,用于鉴定和区分 SARS-CoV-2 变异株 B.1.1.7 和 B.1.351
Microbiol Spectr. 2021 Oct 31;9(2):e0050621. doi: 10.1128/Spectrum.00506-21. Epub 2021 Oct 6.
6
A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR.基于 SYBR Green 的 RT-qPCR 快速、低成本检测 SARS-CoV-2 B.1.1.7 谱系的方法。
Mol Biol Rep. 2021 Nov;48(11):7243-7249. doi: 10.1007/s11033-021-06717-y. Epub 2021 Oct 6.
7
Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.通过 ddPCR 特异性等位基因鉴别检测 N501Y 和其他 SARS-CoV-2 突变可鉴定华盛顿州的 B.1.1.7 谱系。
J Med Virol. 2021 Oct;93(10):5931-5941. doi: 10.1002/jmv.27155. Epub 2021 Jul 3.
8
SARS-CoV-2 variant survey: Comparison of RT-PCR screening with TGS and variant distribution across two divisions of Bangladesh.SARS-CoV-2 变体调查:实时荧光 RT-PCR 筛查与 TGS 的比较,以及孟加拉国两个行政区的变体分布。
PLoS One. 2024 Oct 17;19(10):e0311993. doi: 10.1371/journal.pone.0311993. eCollection 2024.
9
Variant Prediction by Analyzing RdRp/S Gene Double or Low Amplification Pattern in Allplex SARS-CoV-2 Assay.通过分析Allplex SARS-CoV-2检测中RdRp/S基因双重或低扩增模式进行变异预测
Diagnostics (Basel). 2021 Oct 8;11(10):1854. doi: 10.3390/diagnostics11101854.
10
Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania.短篇通讯:罗马尼亚出现新型 SARS-CoV-2 变种的证据。
AIDS Res Hum Retroviruses. 2021 Apr;37(4):329-332. doi: 10.1089/AID.2021.0009. Epub 2021 Mar 9.

引用本文的文献

1
Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing.加强公共卫生监测:SARS-CoV-2基因组测序中特定平台和混合组装方法的比较研究
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001357.
2
Diagnosis with Metagenomic Next-Generation Sequencing (mNGS) technology and real-time PCR for SARS-CoV-2 Omicron detection using various nasopharyngeal swabs in SARS-CoV-2 Omicron.采用宏基因组下一代测序(mNGS)技术和实时 PCR 对 SARS-CoV-2 奥密克戎进行诊断,使用各种鼻咽拭子进行 SARS-CoV-2 奥密克戎检测。
PLoS One. 2024 Aug 6;19(8):e0305289. doi: 10.1371/journal.pone.0305289. eCollection 2024.
3
A Highly Sensitive Immunoassay for Determination of Immune Response to SARS-CoV-2 in Capillary Blood Samples.
一种用于测定毛细血管血样中对SARS-CoV-2免疫反应的高灵敏度免疫测定法。
Biomedicines. 2022 Nov 11;10(11):2897. doi: 10.3390/biomedicines10112897.
4
Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern.N501Y、E484K/Q、K417N/T、L452R 和 T478K 突变对 SARS-CoV-2 刺突蛋白 RBD 的理化效应及其对病原体适应性和新兴关切变异株所产生特性的影响。
Virology. 2022 Jul;572:44-54. doi: 10.1016/j.virol.2022.05.003. Epub 2022 May 12.
5
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia.B.1.1.7 谱系的局部出现和快速传播:弗留利-威尼斯朱利亚大区的一瞥。
PLoS One. 2021 Dec 14;16(12):e0261229. doi: 10.1371/journal.pone.0261229. eCollection 2021.
6
Variant Prediction by Analyzing RdRp/S Gene Double or Low Amplification Pattern in Allplex SARS-CoV-2 Assay.通过分析Allplex SARS-CoV-2检测中RdRp/S基因双重或低扩增模式进行变异预测
Diagnostics (Basel). 2021 Oct 8;11(10):1854. doi: 10.3390/diagnostics11101854.
7
Different Strategies for the Identification of SARS-CoV-2 Variants in the Laboratory Practice.不同策略在实验室实践中鉴定 SARS-CoV-2 变异株。
Genes (Basel). 2021 Sep 16;12(9):1428. doi: 10.3390/genes12091428.
8
Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection.基于 N 基因缺失或延迟的诊断预筛选方法,提高 SARS-CoV-2 VOC B.1.1.7 检测的可行性。
Diagn Microbiol Infect Dis. 2021 Dec;101(4):115491. doi: 10.1016/j.diagmicrobio.2021.115491. Epub 2021 Jul 16.
9
Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation.突变特异性 SARS-CoV-2 PCR 筛查:快速准确检测关注变体,并鉴定出具有 Spike L452R 突变的新出现变体。
J Clin Microbiol. 2021 Jul 19;59(8):e0092621. doi: 10.1128/JCM.00926-21.